Evidence map›Paper›PMID 40291516›Full record

ArticleFrontiers in psychiatry2025

Evoked craving in high-dose benzodiazepine users.

Lorenzo Zamboni, Giulia Benvegnù, Francesca Fusina, Roberta Vesentini, Francesca Locatelli, Matteo Mattiello, Vanessa Mannari, Simone Campagnari, Silvia Toldo, Alessio Congiu and 4 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lorenzo ZamboniUnit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy.
Giulia BenvegnùDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Francesca FusinaDepartment of General Psychology, University of Padova, Padova, Italy.
Roberta VesentiniDiagnostics and Public Health-Unit of Epidemiology and Medical Statistics, University of Verona, Verona, Italy.
Francesca LocatelliDiagnostics and Public Health-Unit of Epidemiology and Medical Statistics, University of Verona, Verona, Italy.
Matteo MattielloUnit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy.
Vanessa MannariCenter for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Bologna, Italy.
Simone CampagnariUnit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy.
Silvia ToldoDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Alessio CongiuUnit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy.
Maria BrendolanUnit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy.
Giuseppe VerlatoDiagnostics and Public Health-Unit of Epidemiology and Medical Statistics, University of Verona, Verona, Italy.
Cristiano ChiamuleraDepartment of Diagnostics and Public Health, University of Verona, Verona, Italy.
Fabio LugoboniUnit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Benzodiazepines (BDZs) are among the most abused substances worldwide, and high-dose BDZ abuse is considered a specific type of addiction. Cue reactivity (CR) is a hypersensitivity to motivational stimuli and, in substance use disorders, it increases craving and facilitates relapse, especially in chronic users. Virtual reality (VR) may be a viable technology to implement in CR paradigms. The general objective of this study is the implementation of a VR protocol to identify the causal relationship between the environmental features of a specific setting and craving responses in BDZ abusers. Methods: Moreover, we investigated the correlation between the degree of BDZ craving and measures of mood, affect, attention, sense of presence, and cybersickness in the subjects, and evaluated the effectiveness that different VR environments have in discriminating between BDZ abusers and controls by comparing the degree of BDZ craving and all of the aforementioned variables in the two groups. Results: Our data suggest that cues can indeed become conditioned to elicit craving responses in high-dose BDZ abusers, but more studies are necessary to confirm this hypothesis. Conclusion: Moreover, the use of VR can be a good choice to observe environmental craving for BDZs since it presents a realistic simulation of real-world settings.

Indexed as

abuseaddictionbenzodiazepinecue reactivityvirtual reality

Identifiers

PMID40291516
PMCPMC12021859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.